Showing results (1-10 of 429) with videos related to
Sort By:
Pageof 43
The Journal of Investigative Dermatology|January 24, 2017
Imatinib in Dermatofibrosarcoma: Targeted Therapy or Immunotherapy?Selma Ugurel, Jürgen C BeckerCancer Control : Journal of the Moffitt Cancer Center|June 27, 2009
Tumor biomarkers in melanomaSelma Ugurel, Jochen Utikal, Jürgen C BeckerCurrent Opinion in Oncology|January 12, 2012
Merkel cell carcinoma: recent insights and new treatment optionsDavid Schrama, Selma Ugurel, Jürgen C BeckerThe Journal of Investigative Dermatology|January 16, 2013
Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agentSelma Ugurel, Annette Paschen, Jürgen C BeckerJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2008
Strategies to optimize the use of targeted agents for tumor therapyJürgen C Becker, Selma Ugurel, David SchramaDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 2019
[Merkel cell carcinoma]Christina Drusio, Jürgen C Becker, Dirk Schadendorf, et al.American Journal of Clinical Dermatology|April 22, 2024
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic UpdatesJürgen C Becker, Andreas Stang, David Schrama, et al.Journal for Immunotherapy of Cancer|January 13, 2026
Merkel cell carcinoma immunotherapy: key questions in the era of immune checkpoint blockadeJürgen C Becker, Georg Lodde, Maximilian Haist, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim MelanomIoana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Update on the clinical use of kinase inhibitors in melanomaIoana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.Pageof 43